Profusa (PFSA) Long-Term Debt Repayments (2025 - 2026)
Profusa posted quarterly Long-Term Debt Repayments of $441000.0 for Q1 2026, down 75.94% on a QoQ basis from $1.8 million in Q4 2025.
Profusa (PFSA) has 2 years of Long-Term Debt Repayments data on file, last reported at $441000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Profusa | 574,294.01 | 574,294.01 | - | 441,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441,000.00 |
| Mar 31, 2026 | 441,000.00 |
| Dec 31, 2025 | 1.83 Mn |
| Dec 31, 2025 | 1.83 Mn |